Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
10.63
-0.49 (-4.41%)
At close: Dec 24, 2024, 4:00 PM
11.16
+0.53 (4.99%)
After-hours: Dec 24, 2024, 4:17 PM EST
Neumora Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Cash & Equivalents | 275.71 | 374.04 | 240.94 | 409.25 | 191.98 | - |
| Short-Term Investments | 65.59 | 79.94 | 130.94 | - | - | - |
| Cash & Short-Term Investments | 341.31 | 453.98 | 371.88 | 409.25 | 191.98 | - |
| Cash Growth | -33.02% | 22.08% | -9.13% | 113.18% | - | - |
| Other Receivables | - | 0.94 | 0.92 | 0.2 | 0.15 | - |
| Receivables | - | 0.94 | 0.92 | 0.2 | 0.15 | - |
| Prepaid Expenses | 6.09 | 4.27 | 1.62 | 1.2 | 0.78 | - |
| Restricted Cash | 1.21 | - | 0.05 | 0.13 | 0.13 | - |
| Other Current Assets | - | 19.09 | 13.48 | 4.84 | 0.81 | - |
| Total Current Assets | 348.61 | 478.28 | 387.96 | 415.6 | 193.84 | - |
| Property, Plant & Equipment | 3.93 | 6.86 | 10.64 | 4.04 | 3.92 | - |
| Long-Term Investments | - | 9.85 | 23.51 | - | - | - |
| Long-Term Deferred Charges | - | - | 2.9 | 1.83 | - | - |
| Other Long-Term Assets | - | 1.21 | 1.23 | 7.82 | 0.18 | - |
| Total Assets | 352.54 | 496.2 | 426.23 | 429.3 | 197.95 | - |
| Accounts Payable | 6.11 | 0.34 | 7.15 | 1.64 | 2.4 | - |
| Accrued Expenses | 22.76 | 21.26 | 11.54 | 19.1 | 5.6 | 0.02 |
| Current Portion of Leases | 2.75 | 3.38 | 3.37 | 1.06 | 0.76 | - |
| Other Current Liabilities | 0.13 | 0.14 | 1.64 | 1.49 | 0.61 | - |
| Total Current Liabilities | 31.74 | 25.11 | 23.7 | 23.28 | 9.37 | 0.02 |
| Long-Term Leases | - | 1.85 | 5.07 | 1 | 1.28 | - |
| Other Long-Term Liabilities | 0.06 | 0.16 | 0.63 | 0.39 | - | - |
| Total Liabilities | 31.8 | 27.12 | 29.4 | 24.66 | 10.65 | 0.02 |
| Common Stock | 0.02 | 0.02 | 0 | 0.01 | 0.01 | - |
| Additional Paid-In Capital | 1,209 | 1,173 | 21.43 | 11.37 | 4.9 | - |
| Retained Earnings | -888.4 | -703.43 | -467.51 | -336.61 | -99.29 | -0.02 |
| Comprehensive Income & Other | 0.11 | -0.08 | -0.77 | - | - | - |
| Total Common Equity | 320.74 | 469.08 | -446.85 | -325.22 | -94.38 | -0.02 |
| Shareholders' Equity | 320.74 | 469.08 | 396.84 | 404.64 | 187.3 | -0.02 |
| Total Liabilities & Equity | 352.54 | 496.2 | 426.23 | 429.3 | 197.95 | - |
| Total Debt | 2.75 | 5.23 | 8.44 | 2.05 | 2.05 | - |
| Net Cash (Debt) | 338.56 | 458.6 | 386.95 | 407.2 | 189.93 | - |
| Net Cash Growth | -34.05% | 18.51% | -4.97% | 114.39% | - | - |
| Net Cash Per Share | 2.15 | 7.05 | 14.22 | 18.60 | 14.61 | - |
| Filing Date Shares Outstanding | 161.56 | 158.89 | 32.61 | 31.98 | 30.61 | - |
| Total Common Shares Outstanding | 160.48 | 158.83 | 32.61 | 31.98 | 30.61 | - |
| Working Capital | 316.87 | 453.17 | 364.26 | 392.33 | 184.47 | -0.02 |
| Book Value Per Share | 2.00 | 2.95 | -13.70 | -10.17 | -3.08 | - |
| Tangible Book Value | 320.74 | 469.08 | -446.85 | -325.22 | -94.38 | -0.02 |
| Tangible Book Value Per Share | 2.00 | 2.95 | -13.70 | -10.17 | -3.08 | - |
| Machinery | - | 3.18 | 2.94 | 2.3 | 1.83 | - |
| Construction In Progress | - | 0.04 | 0.51 | 0.22 | - | - |
| Leasehold Improvements | - | - | 0.02 | 0.26 | 0.21 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.